Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Clinical Infectious Diseases

• Publication date

  2001-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/320903PMID 11389521
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Post-transplant lymphoproliferative disorder: a review

  2003cited by this paper
• Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients.

  2000cited by this paper
• Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation.

  2000cited by this paper
• Detection of Epstein-Barr Virus DNA in Sera from Transplant Recipients with Lymphoproliferative Disorders

  1999cited by this paper
• Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

  1999cited by this paper
• THE ROLE OF ADOPTIVE IMMUNOTHERAPY IN THE PREVENTION AND TREATMENT OF LYMPHOPROLIFERATIVE DISEASE FOLLOWING TRANSPLANTATION

  1999cited by this paper
• Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression.

  1999cited by this paper
• Prospective longitudinal analysis of quantitative Epstein-Barr virus polymerase chain reaction in pediatric liver transplant recipients.

  1999cited by this paper
• Interleukin-10 and posttransplant lymphoproliferative disorder after kidney transplantation.

  1999cited by this paper
• Cyclosphosphamide/prednisone for combination immunosuppression and therapy of lymphoproliferative disease.

  1999cited by this paper
• Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.

  1999cited by this paper
• Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation.

  1999cited by this paper
• Lymphoproliferative disorders after organ transplantation in children.

  1999cited by this paper
• Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: use of aciclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol.

  1999cited by this paper
• Epstein-barr virus-induced posttransplant lymphoproliferative disorders

  1999cited by this paper
• Monitoring of Epstein-Barr Virus DNA Load in Peripheral Blood by Quantitative Competitive PCR

  1999cited by this paper
• Cytokine mRNA profiles in Epstein–Barr virus‐associated post‐transplant lymphoproliferative disorders

  1999cited by this paper
• Epstein-Barr Virus–Infected Resting Memory B Cells, Not Proliferating Lymphoblasts, Accumulate in the Peripheral Blood of Immunosuppressed Patients

  1999cited by this paper
• Epstein-Barr virus infections in children after transplantation of the small intestine.

  1998cited by this paper
• Epstein-Barr Virus Polymerase Chain Reaction and Serology in Pediatric Post-Transplant Lymphoproliferative Disorder: Three-Year Experience

  1998cited by this paper
• Posttransplantation lymphoproliferative disorder associated with OKT3 and decreased antiviral prophylaxis in pancreas transplant recipients.

  1998cited by this paper
• Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants.

  1998cited by this paper
• Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.

  1998cited by this paper
• Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome.

  1998cited by this paper
• Successful treatment of post‐transplant lymphoproliferative disorder with interferon‐alpha and intravenous immunoglobulin 1

  1998cited by this paper
• Interferon-alpha and its effects on post-transplant lymphoproliferative disorders.

  1998cited by this paper
• Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders.

  1998cited by this paper
• Posttransplant lymphoproliferative disorders and gastrointestinal manifestations of Epstein-Barr virus infection in children following liver transplantation.

  1998cited by this paper
• Effects of immunotherapy on experimental immunodeficiency-related lymphoproliferative disease.

  1998cited by this paper
• Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease.

  1998cited by this paper
• Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.

  1998cited by this paper
• Epstein-Barr virus PCR correlated with viral histology and serology in pediatric liver transplant patients.

  1997cited by this paper
• Acute renal allograft rejection in patients with Epstein‐Barr virus associated post‐transplant lymphoproliferative disorder

  1997cited by this paper
• Retransplantation after post-transplant lymphoproliferative disease

  1997cited by this paper
• Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease.

  1997cited by this paper
• Remission of posttransplant lymphoproliferative disorder after interferon alfa therapy.

  1997cited by this paper
• Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus.

  1997cited by this paper
• Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients.

  1997cited by this paper
• Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders

  1997cited by this paper
• Human immunoglobulin preparations suppress the occurrence of Epstein-Barr virus-associated lymphoproliferation.

  1997cited by this paper
• Epstein-Barr virus lymphoproliferative disorders after liver transplantation.

  1997cited by this paper
• IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma.

  1997cited by this paper
• Incidence and consequences of post-transplantation lymphoproliferative disorders.

  1997cited by this paper
• Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop.

  1997cited by this paper
• Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy.

  1997cited by this paper
• Epstein-Barr virus transmission from a blood donor to an organ transplant recipient with recovery of the same virus strain from the recipient's blood and oropharynx.

  1996cited by this paper
• Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.

  1996cited by this paper
• Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder.

  1996cited by this paper
• Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients.

  1996cited by this paper
• Effects of interferon-α therapy on immune parameters in immune thrombocytopenic purpura

  1996cited by this paper
• Interferon-alpha affects the immune response in post-transplant lymphoproliferative disorder.

  1996cited by this paper
• Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.

  1996cited by this paper
• Incidence of post‐transplant malignancy among 674 solid‐organ‐transplant recipients at a single center

  1996cited by this paper
• Effects of interferon-alpha therapy on immune parameters in immune thrombocytopenic purpura.

  1996cited by this paper
• Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease.

  1996cited by this paper
• Early identification of Epstein‐Barr virus‐associated post‐transplantation lymphoproliferative disease

  1995cited by this paper
• Aggressive treatment for postcardiac transplant lymphoproliferation.

  1995cited by this paper
• Pretransplantation assessment of the risk of lymphoproliferative disorder.

  1995cited by this paper
• An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation.

  1995cited by this paper
• Antiviral prophylaxis and the Epstein Barr virus‐related post‐transplant lymphoproliferative disorder

  1995cited by this paper
• INCIDENCE, DETERMINANTS, AND CONSEQUENCES OF SUBCLINICAL NONCOMPLIANCE WITH IMMUNOSUPPRESSIVE THERAPY IN RENAL TRANSPLANT RECIPIENTS

  1995cited by this paper
• EPSTEIN‐BARR VIRUS DNA IN PERIPHERAL BLOOD LEUKOCYTES OF PATIENTS WITH POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE

  1995cited by this paper
• Central Nervous System Lymphomas In Organ Allograft Recipients

  1995influential reference
• CLINICAL IMPACT OF REPLACING MINNESOTA ANTILYMPHOCYTE GLOBULIN WITH ATGAM

  1995cited by this paper
• Epstein‐Barr virus‐related localized hepatic lymphoproliferative disorders after liver transplantation

  1995cited by this paper
• Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin.

  1995cited by this paper
• Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.

  1995cited by this paper
• Post-transplant lymphoproliferative disorder.

  1995cited by this paper
• Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma.

  1995cited by this paper
• Primary kidney tumors before and after renal transplantation.

  1995cited by this paper
• Interferon-alpha-induced acute renal allograft rejection.

  1995cited by this paper
• INTERFERON-α-INDUCED ACUTE RENAL ALLOGRAFT REJECTION

  1995cited by this paper
• Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.

  1994cited by this paper
• Anti-B cell antibodies for the treatment of monoclonal Epstein-Barr virus-induced lymphoproliferative syndrome after multivisceral transplantation.

  1994cited by this paper
• Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients.

  1994cited by this paper
• Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomas

  1994cited by this paper
• Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomas. French Study Group of Pathology for HIV-associated Tumors.

  1994cited by this paper
• Therapy for transplant-related lymphoproliferative diseases.

  1993cited by this paper
• Epstein-Barr virus detection in sequential biopsies from patients with a posttransplant lymphoproliferative disorder.

  1993cited by this paper
• POST‐TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RENAL ALLOGRAFT RECIPIENTS: CLINICAL EXPERIENCE AND RISK FACTOR ANALYSIS IN A SINGLE CENTER

  1993cited by this paper
• Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders.

  1993cited by this paper
• Posttransplantation lymphoproliferative disorders treated with cyclophosphamide‐doxorubicin‐vincristine‐prednisone chemotherapy

  1993cited by this paper
• TREATMENT OF CENTRAL NERVOUS SYSTEM B LYMPHOPROLIFERATIVE SYNDROME BY LOCAL INFUSION OF A B CELL‐SPECIFIC MONOCLONAL ANTIBODY

  1992influential reference
• In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder.

  1992cited by this paper
• Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder.

  1992cited by this paper
• Immunosuppression ‐ A contributory factor in lymphoma formation

  1992cited by this paper
• Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4

  1991cited by this paper
• Posttransplant lymphoproliferative disease of the liver successfully treated by retransplantation.

  1991cited by this paper
• Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.

  1991cited by this paper
• Lymphoproliferative disorder early after cardiac transplantation.

  1991cited by this paper
• Complete remission and possible immune tolerance after multidrug combination chemotherapy for cyclosporine-related lymphoma in a renal transplant recipient with acute pancreatitis.

  1991cited by this paper
• Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.

  1990cited by this paper
• Renal retransplantation in patients who lost their allografts during management of previous post‐transplant lymphoproliferative disease

  1990cited by this paper
• Epstein-Barr virus--determined clonality in posttransplant lymphoproliferative disease.

  1990cited by this paper
• Cytologic findings in posttransplant lymphoproliferative disease.

  1990cited by this paper
• Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft.

  1989cited by this paper
• Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation.

  1989cited by this paper
• Basic virological aspects of Epstein-Barr virus infection.

  1988cited by this paper
• ADVERSE EFFECT OF LOW‐DOSE PROPHYLACTIC HUMAN RECOMBINANT LEUKOCYTE INTERFERON‐ALPHA TREATMENT IN RENAL TRANSPLANT RECIPIENTS: Cytomegalovirus Infection Prophylaxis Leading to an Increased Incidence of Irreversible Rejections

  1988cited by this paper
• The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.

  1988cited by this paper

• Machine Learning-Based Evaluation of Combined EBV and CMV Serostatus as Predictors of Post-Transplant Lymphoproliferative Disorder.

  2026cites this paper
• Epstein-Barr virus (EBV) infection and associated post transplantation lymphoproliferative disease (PTLD) in hematopoietic stem cell transplantation (HSCT): a prevalence based systematic review and meta-analysis on global epidemiology

  2025cites this paper
• Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disorders

  2024cites this paper
• Limited utility of Epstein-Barr virus (EBV) surveillance for predicting post-transplant lymphoproliferative disorders in adult EBV seropositive lung transplant recipients.

  2024cites this paper
• Isolated Muscular NK/T Cell Lymphoma: A Rare Presentation of Post-Transplant Lymphoproliferative Disorders

  2024cites this paper
• Post-transplant malignancy: Focusing on virus-associated etiologies, pathogenesis, evidence-based management algorithms, present status of adoptive immunotherapy and future directions

  2023cites this paper
• The prevalence of latent/chronic infection in liver transplant candidates in Taleghani Hospital of Tehran, Iran, from 2020 until 2021

  2023cites this paper
• Role of Cytomegalovirus in the Development of Posttransplant Lymphoproliferative Disorders With or Without Epstein-Barr Virus Infection.

  2022cites this paper
• Post-transplant lymphoproliferative disease after pediatric kidney transplant

  2022cites this paper
• Cancer risk associated with cytomegalovirus infection among solid organ transplant recipients in the United States

  2022cites this paper
• Lymphoproliferative Disease in a Non-Transplant Patient and Spironolactone's Activity Against Epstein Barr Virus.

  2021cites this paper
• Epstein‐Barr viral load monitoring for diagnosing post‐transplant lymphoproliferative disorder in pediatric liver transplant recipients

  2020cites this paper
• Thiopurines in Pediatric Inflammatory Bowel Disease: Current and Future Place

  2020cites this paper
• Long‐term remission in an adult heart transplant recipient with advanced Burkitt’s lymphoma post‐transplant lymphoproliferative disorder after anthracycline‐free chemotherapy: A case report and literature review

  2020cites this paper
• Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring

  2020cites this paper
• Post-renal transplant malignancies: Opportunities for prevention and early screening.

  2020cites this paper
• Infectious Issues After Pancreas Transplant

  2019cites this paper
• Screening of donor and candidate prior to solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

  2019cites this paper
• 1 Infectious Complications in Kidney Transplantation

  2019cites this paper
• A case report of nodal CD4-positive T-cell lymphoproliferative disorder with an indolent course

  2018cites this paper
• Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder

  2018cites this paper
• Posttransplant Lymphoproliferative Disorder in Solid Organ and Hematopoietic Stem Cell Transplantation.

  2017cites this paper
• Lymphoproliferative disorder in a twin female teenager post kidney transplantation.

  2017cites this paper
• Complications of Immunosuppressive Drugs Toxicity Malignant disease Infection Nephrotoxicity Hypertension Hyperlipidemia Neurotoxicity Diabetes Osteoporosis Gingival hyperplasia Acne Hirsutism Alopecia Gastrointestinal toxicity Heme toxicity

  2016cites this paper
• Lower Respiratory Tract Infections

  2016influential citation
• EBV Status and Thiopurine Use in Pediatric IBD

  2016cites this paper
• Automated quantification of Epstein-Barr Virus in whole blood of hematopoietic stem cell transplant patients using the Abbott m2000 system.

  2016cites this paper
• 141 – Epstein-Barr Virus (Infectious Mononucleosis, Epstein-Barr Virus–Associated Malignant Diseases, and Other Diseases)

  2015cites this paper
• Microenvironmental abnormalities induced by viral cooperation: Impact on lymphomagenesis.

  2015cites this paper
• Small Intestinal Lymphoma in a Post-Renal Transplant Patient: A Rare Case with Late Presentation

  2014cites this paper
• Localization of post-transplant lymphoproliferative disorders to the stomach might be associated with favorable outcome: a systematic review.

  2014cites this paper
• Large granular lymphocytic leukemia presenting late after solid organ transplantation: a case series of four patients and review of the literature.

  2014cites this paper
• Chapter 35 – Cancer in Dialysis and Kidney Transplant Patients

  2014cites this paper
• Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study.

  2013cites this paper
• Screening of Donor and Recipient in Solid Organ Transplantation

  2013cites this paper
• Pediatric Liver Transplantation

  2013cites this paper
• Posttransplant Lymphoproliferative Disorder of the Central Nervous System

  2013cites this paper
• Late Onset Epstein Barr Virus Seropositive Posttransplant Lymphoproliferative Disorder in Two Renal Transplant Receivers

  2013cites this paper
• Complications of Kidney Transplantation: Effects of Over-Immunosuppression

  2012cites this paper
• Post-Transplant Lymphoproliferative Disease – PTLD

  2012cites this paper
• Everolimus Associated with Activated Vitamin D for Post-Transplant Increase Epstein-Barr-Virus Load Treatment. Two Case Reports

  2012cites this paper
• Post-transplantation lymphoproliferative disorder (PTLD) twenty years after heart transplantation: a case report and review of the literature

  2011cites this paper
• Paediatric Transplantation

  2011cites this paper
• Treating rheumatic patients with a malignancy

  2011cites this paper
• Malignant disease Rheumatic disease Natural course Treatment Treatment

  2011cites this paper
• Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab.

  2011cites this paper
• Infectious Complications in Kidney Transplantation

  2011cites this paper
• Herpes viruses in transplant recipients: HSV, VZV, human herpes viruses, and EBV.

  2011cites this paper
• EBV-Associated Polymorphic Posttransplant Lymphoproliferative Disorder Presenting as Gingival Ulcers

  2011cites this paper
• Tacrolimus (FK506): Safety and Applications in Reconstructive Surgery

  2010cites this paper
• A pain in the bone.

  2010cites this paper
• Herpes viruses in transplant recipients: HSV, VZV, human herpes viruses, and EBV.

  2010cites this paper
• Hand transplantation and vascularized composite tissue allografts in orthopaedics and traumatology.

  2010cites this paper
• Transplantation de main et allotransplantations vascularisées composites en Orthopédie-Traumatologie

  2010cites this paper
• Clinical Features and Diagnostic Evaluation of Posttransplant Lymphoproliferative Disorder

  2010cites this paper
• Gene expression using microarrays in transplant recipients at risk of EBV lymphoproliferation after organ transplantation: Preliminary proof‐of‐concept

  2009cites this paper
• Infection in Renal Transplant Recipients

  2009cites this paper
• Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary.

  2009cites this paper
• Screening of Donor and Recipient Prior to Solid Organ Transplantation

  2009cites this paper
• Opportunistic infections (non-cytomegalovirus) in live related renal transplant recipients

  2009cites this paper
• Infection in Renal Transplant Recipients

  2009cites this paper
• Chapter 33 – Cancer in Dialysis and Renal Transplant Patients

  2008cites this paper
• Epstein-Barr virus related lymphoma in inflammatory bowel disease.

  2008cites this paper
• [A 21-year old male, with a liver transplantation, with short-duration fever, mediastinic lymph nodes and pulmonary infiltrates].

  2008cites this paper
• Microarrays in the Diagnosis of Human Herpesvirus infections

  2008cites this paper
• Adoptive cell therapy against EBV-related malignancies: a survey of clinical results.

  2008cites this paper
• Varón de 21 años, receptor de trasplante hepático, con fiebre, adenopatías mediastínicas e infiltrados pulmonares

  2008cites this paper
• Adoptive cell therapy against EBV-related malignancies: a survey of clinical results

  2008cites this paper
• Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence.

  2008cites this paper
• [Immunosuppression and infection in transplant recipients].

  2007cites this paper
• Medical Progress Infection in Solid-Organ Transplant Recipients

  2007cites this paper
• Infection in renal transplant recipients.

  2007cites this paper
• CMV-, EBV-, and HHV-6-DNAemia after liver transplantation

  2007cites this paper
• Risk assessment in haematopoietic stem cell transplantation: viral status.

  2007cites this paper
• Hand Transplantation: The State-of-the-Art

  2007cites this paper
• Infecciones transmitidas por el donante

  2007cites this paper
• Inmunosupresión e infección en el paciente trasplantado

  2007cites this paper
• Selection of Candidates and Waiting List, Dealing with the Media and the Public, Setting Up a Pilot Study, Clinical Trial Organization, Staff Requisites for Hand Transplantation: The Brussels Experience

  2007cites this paper
• Infection in solid-organ transplant recipients.

  2007cites this paper
• Chapter 73 – Infections in Special Hosts

  2007cites this paper
• Risk Assessment of Immunosuppressive Therapy in Facial Transplantation

  2007cites this paper
• Retransplantation After Post‐Transplant Lymphoproliferative Disorders: An OPTN/UNOS Database Analysis

  2006cites this paper
• Epstein Barr virus og malignitet

  2006cites this paper
• American Society of Transplantation Recommendations for Screening, Monitoring and Reporting of Infectious Complications in Immunosuppression Trials in Recipients of Organ Transplantation

  2006cites this paper
• Lymphoma after kidney transplantation: risk factors and timing of development

  2006cites this paper
• [Infections in solid organ transplant recipients].

  2005cites this paper
• Disease of the Month Viral Infection in the Renal Transplant Recipient

  2005cites this paper
• Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients.

  2005cites this paper
• Rituximab as treatment of posttransplant lymphoproliferative disorder in patients who underwent small bowel/multivisceral transplantation: report of three cases.

  2005cites this paper
• Lymphoproliferative disease after lung and heart-lung transplantation: first description in Spain.

  2005cites this paper
• Infecciones en pacientes sometidos a trasplante de órgano sólido

  2005cites this paper
• Langerhans' cell histiocytosis after living donor liver transplantation: Report of a case

  2005cites this paper
• Reactive Epstein-Barr virus-related polyclonal lymphoproliferative disorder in a patient with AIDS.

  2005cites this paper
• Outcome, Incidence, and Timing of Infectious Complications in Small Bowel and Multivisceral Organ Transplantation Patients

  2005cites this paper
• Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease.

  2005cites this paper
• Viral infection in the renal transplant recipient.

  2005cites this paper
• The ABC of Epstein-Barr virus infections.

  2005cites this paper
• Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma.

  2004cites this paper
• Posttransplant Malignancy

  2004cites this paper
• Screening of donor and recipient prior to solid organ transplantation

  2004cites this paper